Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Ophthalmic Drug Delivery Systems

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Risk factors for optic disc hemorrhage in the low-pressure glaucoma treatment study.

American journal of ophthalmology·2014

Same author

Correlation between intereye difference in visual field mean deviation values and relative afferent pupillary response as measured by an automated pupillometer in subjects with glaucoma.

Journal of glaucoma·2013

Same author

Risk factors for visual field progression in the low-pressure glaucoma treatment study.

American journal of ophthalmology·2012

Same author

A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.

American journal of ophthalmology·2011

Same author

Comparison of stereo disc photographs and alternation flicker using a novel matching technology for detecting glaucoma progression.

Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye·2010

Same author

Tissue bioengineering for surgical bleb defects: an animal study.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2008

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Special considerations in low-tension glaucoma.

Theodore Krupin¹

¹Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. krupin@northwestern.edu

Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie

|May 18, 2007

Summary

This review examines neuroprotection strategies for low-pressure glaucoma, a condition affecting optic nerve health. It discusses baseline findings from the Low-Pressure Glaucoma Treatment Study (LoGTS).

More Related Videos

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

Related Experiment Videos

Last Updated: Jul 14, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

Area of Science:

Ophthalmology
Neuroscience

Background:

Low-pressure glaucoma (LPG) is a form of optic nerve damage not associated with elevated intraocular pressure.
Neuroprotection aims to preserve neuronal survival and function, crucial for conditions like LPG.

Purpose of the Study:

To review the concept of neuroprotection in the context of low-pressure glaucoma.
To present and analyze the baseline results from the Low-Pressure Glaucoma Treatment Study (LoGTS).

Main Methods:

Literature review on neuroprotection and low-pressure glaucoma.
Analysis of baseline data from the Low-Pressure Glaucoma Treatment Study (LoGTS).

Main Results:

The abstract focuses on the review and baseline data, specific results are pending further analysis.
Baseline data from LoGTS provides a foundation for evaluating treatment efficacy.

Conclusions:

Understanding neuroprotective strategies is vital for managing low-pressure glaucoma.
The LoGTS study provides essential baseline data for future research into LPG treatments.